The development of biologics, gene therapies, cell therapies, and other advanced therapeutics is broadening the scope of preclinical research. CROs are developing specialized capabilities to address the complex testing and characterization requirements associated with these emerging therapeutic modalities.
The Preclinical CROs Market is expanding as pharmaceutical and biotechnology companies...
The global Pharmaceutical CRO Market size was valued at USD 45.3 billion in 2025 and is projected to grow from USD 48.5 billion in 2026 to USD 83.3 billion by 2033, expanding at a CAGR of 8.0% from 2026 to 2033. Asia Pacific accounted for the largest market share of 26.4% in 2025, driven by increasing clinical research activities, expanding pharmaceutical outsourcing, lower...
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek